Resultados de la búsqueda 701-710 of 4422 for Lupus
Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...
Early Detection of Glaucomatous Optic Neuropathy ... Rochester, Minn. The goal of this study is to determine if visual field assessment of the far periphery (60-4) ...
The purpose of this study is to examine patient reported outcomes including pain, quality of life, depression and impact on kidney blood flow before and ...
The purposes of this study are to analyze the ovarian function of female premenopausal melanoma survivors who have undergone immunotherapy, and compare with ...
Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz at the Mayo Clinic, Rochester. Design and ...
Rochester, Minn. The purpose of this study is to evaluate how well the combination of avelumab with liposomal doxorubicin with or without binimetinib, or the ...
The purpose of this study is tol compare the effect of retreatment with 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) to the usual ...
Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...
a de pelo sin otra indicación, Acné, Pénfigo, Lupus, Rosácea, Penfigoide ampolloso, Pioderma gangrenoso, Granuloma anular, Síndrome de Sweet, Liquen plano, ...
Mayo Clinic es una organización sin fines de lucro, y el dinero recaudado con la publicidad en Internet apoya nuestra misión. Mayo Clinic no respalda ningún ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?